Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06495346

Acronym

SomOncoP

Enrollment

Registered

2024-07-10

Start date

2023-12-11

Completion date

2025-03-25

Last updated

2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cell Lung Cancer, Sleep Disorders

Brief summary

This exploratory study will identify and characterise disorders frequently reported by patients as contributing to or altering their quality of life. This will enable a decision tree to be drawn up for diagnosis, referral and treatment of the sleep disorders collected, tailored to patients in this population. This decision tree should help to improve the management of patients with a cancer diagnosis presenting with sleep disorders.

Interventions

OTHERself-questionnaires exploring

At each stage, subjects are asked to fill in self-questionnaires exploring the quality of their sleep, their potential distressing symptoms, their psychological state and the quality of their life at that moment. They complete the self-questionnaires at t

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patient aged 18 and over. * Being monitored and treated for non-small cell lung cancer. * With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30). * With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG \<2). * Able to understand the study documents written in French * Able to complete the study questionnaires written in French. * Contactable by telephone throughout the study * Affiliated to a social security scheme or entitled beneficiary * Not opposed to taking part in the study

Exclusion criteria

* Patient refusing to take part in the study * With a mental illness of the psychosis type monitored and treated prior to the study * Patient under guardianship or curatorship * Patient under court protection

Design outcomes

Primary

Measure	Time frame	Description
Score sleep quality criteria (Pittsburgh Sleep Quality Index)	Every 14 days for 2 months	The overall score ranging from 0 to 21 points. A score of 0 means that there is no difficulty sleeping, and 21 indicates, on the contrary, major difficulties.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026